Enzo Biochem, Inc.
Enzo Biochem, Inc. (ENZB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENZB · as of Jun 9, 2026
Key Statistics
Explore Enzo Biochem, Inc. Data
enzb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
enzb competitorsENZB
ACOGF
CSWYY
DMTTF
IGXT
MDPEFStock Performance
Full HistoryAbout Enzo Biochem, Inc.
Enzo Biochem, Inc. operates as an integrated entity encompassing diagnostics, clinical laboratory services, and life sciences. The company is dedicated to developing, manufacturing, and commercializin…
what is enzo biochem, inc. · enzb stock overview · enzo biochem, inc. company profile · who is enzo biochem, inc. ceo · enzb OTC · enzo biochem, inc. headquarters · enzo biochem, inc. business segments
About Stock Overview & Key Data
Enzo Biochem, Inc. (ENZB) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Jun 12, 1980. As of the latest trading session, ENZB stock price is $0.70, with a market capitalization of $36.6M. The stock has returned -37.04% over the past 12 months and -2.95% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Enzo Biochem, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Enzo Biochem, Inc. reported revenue of $31.9M and net income of -$26.1M. For detailed data — including Enzo Biochem, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enzo Biochem, Inc. (ENZB) stock price is $0.70. The stock is traded on OTC under the ticker symbol ENZB. The 52-week range is $0.25 – $1.19.